Enzymes in Drug Discovery Summit 2018
  • GTCbio conferences aim to facilitate transformational platforms that would have a significant impact on scientific research, drug development and healthcare. Identifying and validating new targets is a critical starting point and often times a daunting inflection point in drug development. While there is continuous innovation and invention of new assays and screening technologies, it is important to understand how these technologies will help with new and existing targets.

    Protein Kinases have long been an important target in several diseases and we will discuss new developments in this area at our 2018 Enzymes in Drug Discovery Summit. We will also focus on advances in Ubiquitin and Protease targeted therapies.

    protein conference

Witaj, nieznajomy!

Wygląda na to, że jesteś tutaj nowy. Jeśli chcesz wziąć udział, należy kliknąć jeden z tych przycisków!